PS Ratio:
454.38+8.97(+2.01%)Summary
- As of today, XENE price to sales ratio is 454.38, with a rise of +8.97 (+2.01%) during the most recent trading session on December 19, 2025.
- XENE PS ratio is now -97.81% below its all-time high of 20.78 thousand.
Performance
XENE PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
XENE PS Ratio Trends
| PeriodPeriod | PS RatioPS Ratio | PricePrice | Market CapMarket Cap | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | +2.0% | +2.0% | +2.0% | 0.0% |
| 1M1 Month | +8.5% | +8.5% | +8.5% | - |
| 3M3 Months | +19.6% | +19.4% | +19.6% | 0.0% |
| 6M6 Months | +39.2% | +38.2% | +39.2% | - |
| YTDYTD | - | +12.5% | +13.8% | - |
| 1Y1 Year | - | +13.4% | +14.9% | +100.0% |
| 5Y5 Years | +2885.4% | +234.3% | +638.0% | -75.3% |
XENE PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 463.75 | -2.0% | 414.92 | +9.5% |
| 3M | 3-Month | 463.75 | -2.0% | 375.45 | +21.0% |
| 6M | 6-Month | 463.75 | -2.0% | 310.84 | +46.2% |
| 1Y | 1-Year | 463.75 | -2.0% | 288.30 | +57.6% |
| 3Y | 3-Year | 19.31K | -97.7% | 179.02 | +153.8% |
| 5Y | 5-Year | 19.31K | -97.7% | 14.86 | +2957.7% |
| All-Time | All-Time | 20.78K | -97.8% | 4.45 | >+9999.0% |
XENE PS Ratio History
| Date | Value |
|---|---|
| 2025 | 454.38(+73.7%) |
| 2022 | 261.59(+199.0%) |
| 2021 | 87.49(+422.6%) |
| 2020 | 16.74(-69.0%) |
| Date | Value |
|---|---|
| 2019 | 54.02(-67.0%) |
| 2017 | 163.49(+113.5%) |
| 2016 | 76.58(+932.1%) |
| 2015 | 7.42(-24.8%) |
| 2014 | 9.87 |
FAQ
- What is Xenon Pharmaceuticals Inc. price to sales ratio?
- What is the all-time high PS ratio for Xenon Pharmaceuticals Inc.?
What is Xenon Pharmaceuticals Inc. price to sales ratio?
The current PS ratio of XENE is 454.38
What is the all-time high PS ratio for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high price to sales ratio is 20.78K